Trial intelligence / Profile preview

Cannabinoids As An Adjunct For Reducing Pain (Carp)- TCH

NCT06834997Phase 2Withdrawn

Sponsor
Baylor College of Medicine
Start
Apr 2026
Primary completion
Mar 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dronabinol in endometriosis, sponsored by Baylor College of Medicine. Planned start Apr 2026; status: withdrawn.

02

Drugs

dronabinol
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT06834997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06834997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call